Thermo Scientific’s Post

🚨 Multidrug-resistant organisms (MDROs) and healthcare-associated infections (HAIs) are critical threats to patient health and impose substantial financial burdens on healthcare systems. Extended hospital stays. Costly treatments. Risks to larger patient populations. Explore our new infographic, Superbug Surcharge: The Economics of MDROs and HAIs, to understand the financial and patient impacts of superbugs 🦠. Discover how advancements in screening, detection, and treatment can mitigate these challenges, leading to improved patient outcomes: http://spr.ly/6042QaDE8

We are pleased to announce the publication of a first-of-its-kind study that assesses the consequences of device-detected atrial fibrillation (AF).¹ The results provide further understanding of true AF-associated mortality and healthcare utilization, which is important in informing prevention and treatment efforts.¹ Read the study: https://bit.ly/4f7DhLP

In our review of healthcare trends in mitochondrial disease for 2024, we highlight advancements in precision medicine, digital health technologies, interdisciplinary collaboration, and patient-centred care models. These innovations are setting new standards in the treatment and management of mitochondrial diseases. Read the full report here: https://lnkd.in/geC4jMru 

Chronic diseases are a leading cause of death and disability worldwide, affecting millions of individuals and placing a significant burden on healthcare systems. According to the World Health Organization, chronic diseases account for nearly 70% of all deaths globally. Dr Anurag Bansal, Technical Director, Agilus Diagnostics emphasized about the role of diagnostic labs in managing chronic diseases. Read the full article in the July Edition of Pharma Bio World Magazine #AgilusDiagnostics #Chronicdiseases

🌐 Strengthening diagnostic capacity is key to combating antimicrobial resistance. The World Health Organization Health Assembly highlights the critical need for improved diagnostics at every stage of care. By enhancing local production and ensuring access to quality diagnostics, we can empower medical professionals to make informed decisions, reduce the spread of resistance, and protect patient health globally. Let's lead the charge in advancing diagnostics for a healthier future. Learn more here: https://lnkd.in/envyH88R #GlobalHealth #Diagnostics #Innovation #AMR Image credit World Health Organization

ACS NSQIP How It Works.... It collects data on preoperative risk factors, preoperative laboratory values, intraoperative variables, 30-day postoperative mortality, and 30-day morbidity on all patients undergoing major operations which meet program criteria.

It is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO's prequalification standards. WHO prequalification of this test is expected to assure the quality of diagnostic tests used to improve access to early diagnosis and treatment. It complements public health approaches, which is grounded in emerging evidence, diagnostic accuracy, and patient outcomes alongside considerations for accessibility and equity, with prequalification requirements on quality, safety, and performance.

PREDICT-SpA: Evaluating the influence of gender on disease assessment tools Dr. Sheila Reyes reports on abstract 0571, Gender-specific Performance of Disease Activity Assessment Tools in Axial Spondyloarthritis: Ancillary Analysis of the PREDICT-SpA Study, presented at #ACR24. https://buff.ly/4fOO3aI

According to WHO’s statistics, the NCDs (non-communicable diseases) progression, the morbidity and mortality trends are highly changing day by day. Healthcare professionals have to be adaptable with this transformative era and they are always discovering the new innovative approaches of preventive and curative medicine using the updated state-of-the-art technologies. We make a difference of better healthcare services for our people to achieve the higher quality of life. #ARYUinternationalhospital #GlobalCareWithinReach #betterqualityoflife #preventiveandcurativemedicine #tertiarycare

🔬 Dr. Rob Fraser, President of Molecular You, joins this episode of Outcomes Rocket to delve into the game-changing impact of digital health on patient empowerment. Learn how Molecular You's personalized approach, analyzing 250+ blood markers, revolutionizes early intervention and disease risk assessment. Discover the future of proactive health management and personalized medicine by tuning in here: https://lnkd.in/g9MY77ay #MolecularYou #DigitalHealth #PersonalizedMedicine